These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26897946)

  • 21. Abdominal wall abscesses in patients with Crohn's disease: clinical outcome.
    Neufeld D; Keidar A; Gutman M; Zissin R
    J Gastrointest Surg; 2006 Mar; 10(3):445-9. PubMed ID: 16504894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
    Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
    Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.
    Kiss LS; Lovasz BD; Golovics PA; Vegh Z; Farkas K; Molnar T; Palatka K; Papp M; Mohas A; Szilagyi BK; Fekete SA; Mandel M; Lakatos PL
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):135-40. PubMed ID: 23799211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical efficacy of nonsurgical treatment of Crohn's disease-related intraabdominal abscess].
    Kim DH; Cheon JH; Moon CM; Park JJ; Han SY; Kim ES; Chung MJ; Lee JH; Jung MK; Lee SH; Son JW; Kim TI; Kim WH
    Korean J Gastroenterol; 2009 Jan; 53(1):29-35. PubMed ID: 19158468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectives.
    Patil SA; Cross RK
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):843-848. PubMed ID: 28633544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-abdominal and pelvic abscess in Crohn's disease: results of noninvasive and surgical management.
    Jawhari A; Kamm MA; Ong C; Forbes A; Bartram CI; Hawley PR
    Br J Surg; 1998 Mar; 85(3):367-71. PubMed ID: 9529495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Brain Imaging Reveals Rapid Blockade of Abdominal Pain Response Upon Anti-TNF Therapy in Crohn's Disease.
    Hess A; Roesch J; Saake M; Sergeeva M; Hirschmann S; Neumann H; Dörfler A; Neurath MF; Atreya R
    Gastroenterology; 2015 Oct; 149(4):864-6. PubMed ID: 26264347
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
    Sands BE; Feagan BG; Rutgeerts P; Colombel JF; Sandborn WJ; Sy R; D'Haens G; Ben-Horin S; Xu J; Rosario M; Fox I; Parikh A; Milch C; Hanauer S
    Gastroenterology; 2014 Sep; 147(3):618-627.e3. PubMed ID: 24859203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How should we treat mild and moderate-severe Crohn's disease in 2017? A brief overview of available therapies.
    Winter RW; Burakoff R
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):95-97. PubMed ID: 27900879
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient outcomes after anti TNF-alpha drugs for Crohn's disease.
    Assasi N; Blackhouse G; Xie F; Marshall JK; Irvine EJ; Gaebel K; Robertson D; Campbell K; Hopkins R; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):163-75. PubMed ID: 20384563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics.
    Jauregui-Amezaga A; Rimola J; Ordás I; Rodríguez S; Ramírez-Morros A; Gallego M; Masamunt MC; Llach J; González-Suárez B; Ricart E; Panés J
    Gut; 2015 Sep; 64(9):1397-402. PubMed ID: 25516418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage.
    Kumar RR; Kim JT; Haukoos JS; Macias LH; Dixon MR; Stamos MJ; Konyalian VR
    Dis Colon Rectum; 2006 Feb; 49(2):183-9. PubMed ID: 16322960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections.
    Temel T; Cansu DÜ; Korkmaz C; Kaşifoğlu T; Özakyol A
    Int J Rheum Dis; 2015 Jan; 18(1):40-5. PubMed ID: 25195983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive histopathologic phenotype in resection specimens from patients with Crohn's disease receiving anti-TNF-α therapy.
    Schaeffer DF; Walsh JC; Kirsch R; Waterman M; Silverberg MS; Riddell RH
    Hum Pathol; 2014 Sep; 45(9):1928-35. PubMed ID: 25022570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of post-operative Crohn's disease in 2017: where do we go from here?
    Nguyen V; Kanth R; Gazo J; Sorrentino D
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1257-1269. PubMed ID: 27678049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of medical management of intraabdominal abscesses in children with Crohn disease.
    Alkhouri RH; Bahia G; Smith AC; Thomas R; Finck C; Sayej W
    J Pediatr Surg; 2017 Sep; 52(9):1433-1437. PubMed ID: 28427855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical impact of preoperative percutaneous drainage of abdominopelvic abscesses in patients with Crohn's disease.
    Bafford AC; Coakley B; Powers S; Greenwald D; Ha CY; Weintraub J; Chessin DB; Gorfine SR; Bauer JJ
    Int J Colorectal Dis; 2012 Jul; 27(7):953-8. PubMed ID: 22249438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
    Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
    Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.